ES Jaffe
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 32
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 16
- Immunology top 1%
- T-cell and Retrovirus Studies 9
- Oncology top 1%
- Viral-associated cancers and disorders 13
- Dermatology top 0.5%
- Cutaneous lymphoproliferative disorders research 7
-
- CNS Lymphoma Diagnosis and Treatment 5
-
- Eosinophilic Disorders and Syndromes 5
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Mark RaffeldL. Jeffrey MedeirosP. A. BunnGP SchechterAF GazdarDarryl ShibataLiu XfYung‐Yi Chen
- Partner nations
- United StatesNetherlandsIndia
In The Last Decade
ES Jaffe
56 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Pathology and Forensic Medicine 2.9k
- Genetics 1.1k
- Immunology 1.9k
- Oncology 2.4k
- Dermatology 686
Countries citing papers authored by ES Jaffe
This map shows the geographic impact of ES Jaffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ES Jaffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ES Jaffe more than expected).
Fields of papers citing papers by ES Jaffe
This network shows the impact of papers produced by ES Jaffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ES Jaffe. The network helps show where ES Jaffe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside ES Jaffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The transcription factor CCAAT/enhancer binding protein (C/EBP)beta is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity | 2006 | 1 |
| 2 | 1999 | 6 | |
| 3 | 鼻および関連した結節外血管中心Tナチュラルキラー細胞リンパ腫に関するワークショップの報告-定義、鑑別診断及び疫学 | 1996 | 3 |
| 4 | 1996 | 122 | |
| 5 | 1995 | 1 | |
| 6 | 1995 | 118 | |
| 7 | 1994 | 125 | |
| 8 | 1994 | 11 | |
| 9 | 1994 | 59 | |
| 10 | c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome. | 1992 | 25 |
| 11 | 1992 | 205 | |
| 12 | Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimens. | 1991 | 5 |
| 13 | 1990 | 63 | |
| 14 | 1988 | 20 | |
| 15 | 1985 | 38 | |
| 16 | 1984 | 9 | |
| 17 | Induction of complement receptors in human cell lines derived from undifferentiated lymphomas. | 1981 | 1 |
| 18 | 1981 | 21 | |
| 19 | 1980 | 279 | |
| 20 | 1978 | 46 |
About ES Jaffe
ES Jaffe is a scholar working on Pathology and Forensic Medicine, Genetics and Immunology, having authored 57 papers that have together received 5.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (16 papers), Viral-associated cancers and disorders (13 papers), T-cell and Retrovirus Studies (9 papers), Cutaneous lymphoproliferative disorders research (7 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.9k citations), Genetics (1.1k citations) and Immunology (1.9k citations). ES Jaffe has collaborated with scholars based in United States, Netherlands and India. Frequent co-authors include Mark Raffeld, L. Jeffrey Medeiros, P. A. Bunn, GP Schechter, AF Gazdar, Darryl Shibata, Liu Xf, Yung‐Yi Chen, Fauci As and DL Longo. Their work appears in journals such as Blood, Leukemia, JNCI Journal of the National Cancer Institute, The American Journal of Surgical Pathology and Infectious Agents and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.